<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>3dheals2017 Archives - 3DHeals</title>
	<atom:link href="https://3dheals.com/tag/3dheals2017/feed/" rel="self" type="application/rss+xml" />
	<link>https://3dheals.com/tag/3dheals2017/</link>
	<description>Discover 3D Bioprinting and Healthcare Innovations</description>
	<lastBuildDate>Sun, 24 Apr 2022 10:11:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://3dheals.com/wp-content/uploads/2020/09/cropped-3D-final-icon-1-1-32x32.jpg</url>
	<title>3dheals2017 Archives - 3DHeals</title>
	<link>https://3dheals.com/tag/3dheals2017/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>3DHeals: 3D printing start-ups demand skill, persistence</title>
		<link>https://3dheals.com/3dheals-3d-printing-start-ups-demand-skill-persistence/</link>
					<comments>https://3dheals.com/3dheals-3d-printing-start-ups-demand-skill-persistence/#respond</comments>
		
		<dc:creator><![CDATA[Eric Barnes]]></dc:creator>
		<pubDate>Mon, 22 May 2017 23:49:20 +0000</pubDate>
				<category><![CDATA[3dheals Community Activities]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Economics]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[AuntMinnie]]></category>
		<category><![CDATA[Biomechanical Testing Facility]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Ideas]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[startups]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[venture capital]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2557</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>By Eric Barnes, AuntMinnie.com staff writer This article was originally published on AuntMinnie.com on April 21st, 2017. &#160; VC Panelists @ Startup Pitch Competition, 3DHEALS2017, San Francisco &#160; April 21, 2017 &#8212; SAN FRANCISCO &#8211; Start-ups are hard enough in any field, but medical device start-ups &#8212; including 3D printing hopefuls &#8212; require extra helpings [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3dheals-3d-printing-start-ups-demand-skill-persistence/">3DHeals: 3D printing start-ups demand skill, persistence</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p class="graf graf--p">By Eric Barnes, AuntMinnie.com staff writer</p>
<p class="graf graf--p"><a href="http://www.auntminnie.com/index.aspx?sec=sup&amp;sub=adv&amp;pag=dis&amp;ItemID=117166">This article was originally published on AuntMinnie.com on April 21st, 2017</a>.</p>
<p>&nbsp;<img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/05/1-AP_pfTAn0D9jVZoxthAO2w.jpeg"></p>
<p class="graf graf--p" style="text-align: center;">VC Panelists @ Startup Pitch Competition, 3DHEALS2017, San Francisco</p>
<p style="text-align: left;">&nbsp;</p>
<p><span class="maStartDate">April 21, 2017</span> &#8212; SAN FRANCISCO &#8211; Start-ups are hard enough in any field, but medical device start-ups &#8212; including 3D printing hopefuls &#8212; require extra helpings of dedication and persistence to succeed, according to experts speaking April 20 at the 3DHeals 2017 conference.<br />
Advice about entrepreneurship in 3D printing was dispensed throughout the day from people who had mostly succeeded in their own goals of establishing firms that offer 3D printing services and products that are now in demand. The products include everything from customized breathing masks for sleep apnea patients to replacement limbs for amputees to engineered biological tissues for drug testing.<br />
Dr.&nbsp;Yan Chow, who served as national chief innovation medical officer with Kaiser Permanente for eight years before joining the pharmaceutical firm Amgen, spoke about 3D start-ups from the viewpoint of an equipment buyer interviewing a new technology developer looking for customers. Based on his experience, Chow said he had identified some common patterns and problems with the developers&#8217; approaches.<br />
<strong>Getting the question right</strong><br />
&#8220;What problem are you trying to solve?&#8221; is a key question for entrepreneurs, Chow said. &#8220;In the 2,000 start-ups we saw, a lot of them didn&#8217;t know what problem they were trying to solve.&#8221;<br />
<img decoding="async" src="http://www.auntminnie.com/user/images/content_images/sup_adv/2017_04_21_14_00_45_563_Chow_Yan_175.jpg" alt="Dr.&nbsp;Yan Chow"></p>
<div class="caption"><strong>Dr.&nbsp;Yan Chow at 3DHeals 2017.</strong></div>
<div class="caption">After all, settling on the right problem is a huge part of the calculus that the enterprise buyer goes through.<br />
&#8220;We had tons of start-ups coming to us and saying, &#8216;What problem can we solve for you?&#8217; &#8221; That&#8217;s the wrong question to ask, he said.<br />
In a positive trend, in Chow&#8217;s eight years at Kaiser, the composition of start-up teams he encountered changed from those made up exclusively of engineers to firms that had brought healthcare professionals on board. When healthcare people become part of the equation, they come in saying, &#8220;Here is the evidence, and here&#8217;s the problem I want to solve,&#8221; he said.<br />
3D printing brings a broad array of timing issues, Chow said. One issue of timing is whether the buyer is ready to be sold on any technological innovation. Many large healthcare organizations are still looking for the return on their massive investment in electronic health records, for example. For whatever reason, there may not be a willingness for new solutions right now. And there&#8217;s more to understanding the customer.</div>
<p><strong>Showing your prowess</strong><br />
The team behind the start-up is important, and it needs to show its healthcare prowess. Are there critical gaps in the team makeup? Maybe the start-up boasts a great team that includes a medical school professor and an engineer from a top-flight university such as Stanford &#8212; but its potential customer comes from the University of California, Berkeley.<br />
You can&#8217;t know your customer too well, Chow said. And human skills are extremely important for success.<br />
&#8220;When you go to meet somebody, a lot of it is decided in 10 minutes,&#8221; he said. &#8220;Do they like you and trust you?&#8221;<br />
The start-up won&#8217;t have or be able to afford all the expertise it needs. But does it have resources in place to scale up quickly, if needed?<br />
<strong>Evidence matters</strong><br />
Technology buyers also ask whether there is evidence to back up claims. Maybe your tiny firm hasn&#8217;t found a sponsor for a clinical study yet; however, the executive team must prepare for the question by doing its homework. That means at least talking to potential study sponsors and taking definitive steps toward getting evidence to support the product.<br />
Evidence matters &#8220;because in healthcare the stakes are very high &#8212; life or death, in fact &#8212; and the regulatory barriers are formidable,&#8221; Chow said. &#8220;Many healthcare start-ups underestimate the barriers. New technology poses a couple of problems: one, that there&#8217;s no track record, and two, that there&#8217;s no agreement on what constitutes success and how it should be measured. These are not small issues.&#8221;<br />
Is your product HIPAA compliant? Do you have 510(k) clearance from the U.S. Food and Drug Administration (FDA) to demonstrate your product&#8217;s safety and efficacy? With regard to electronic records and signatures, are you compliant with FDA Title 21, Code of Federal Regulations (CFR) Part 11? Are you protecting your patents at every stage of product development?<br />
Along with the layers of formal regulation are the informal ones, such as community standards of practice and peer-reviewed literature, that cannot be overlooked, Chow said.<br />
Finally, who&#8217;s going to pay for your technology? Has the company lined up insurers ready to reimburse for its use pending 510(k) clearance? Offering an example from the pharmaceutical industry, Chow said one manufacturer is offering a risk-sharing scheme, wherein patients and payors can get their money back if a drug doesn&#8217;t work.<br />
What are other ways to reduce downside risk? Prepare the answers before the pitch, he said.<br />
<strong>Find the star players</strong><br />
As for team building, panelist Leslie Karpas, founder and CEO of custom medical 3D design firm Metamason, said an important win for her firm was securing a principal at a leading healthcare firm to serve as medical director.<br />
This individual &#8220;knows all of the major players in the space, all the major points of sale, and all the former executives from all the big companies that are in retirement mode that we&#8217;re now trying to hit up for funding,&#8221; he said.<br />
Another key hire was a former director of clinical affairs from another large firm, who is writing Metamason&#8217;s clinical protocols.<br />
&#8220;You can hang yourself with clinical protocols really quickly if you&#8217;re not careful,&#8221; Karpas said. &#8220;We ended up scrapping ours and rewriting them a number of times because once you are in a trial, whatever you test is what you get. So if you don&#8217;t frame the questions in a really neutral way, you can try to prove something that&#8217;s unprovable, even though there are a lot of other quality elements to what you&#8217;re doing, and then trap yourself. &#8221;<br />
How does a small start-up face the monumental tasks of sorting out regulations, building a team, and trying to obtain financing?<br />
Get a doctor on your team who has a friendly relationship with an institutional review board (IRB) and is able to get approval to try prototypes in patients, Karpas said. Having a doctor who knows doctors who can help in arranging prototype testing can save a lot of time.<br />
Your team should also have an experienced grant writer, which can be contracted out, and your doctor should be experienced in writing clinical trial proposals, preferably from an academic setting, Chow said. This is important because the protocols for the trial, once submitted, are set in stone.<br />
&#8220;For us, we had to look at what we needed and what we could afford. We needed a lot, and we had almost nothing,&#8221; said Dr.&nbsp;Chris Hart, founder of Australia-based 3D firm Oventus.<br />
Spending precious money on consultants with network contacts can be a smart move if they save you time and effort &#8212; and you can take their advice or ignore it, Hart said. Spending on intellectual property patents can also be a wise use of scarce resources. When you need far more than you have, you can also hand out stock options to get the people you need.<br />
All of the panelists agreed that very small firms can save a lot of grief by partnering with a big player.</p>
<p class="graf graf--p graf-after--p" style="text-align: left;"><img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/05/1-mDuwfD0EDy8YTRQa1FKS5A.jpeg"></p>
<p class="graf graf--p" style="text-align: center;">Collage: 3DHEALS2017</p>
<p style="text-align: left;">&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://3dheals.com/3dheals-3d-printing-start-ups-demand-skill-persistence/">3DHeals: 3D printing start-ups demand skill, persistence</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-3d-printing-start-ups-demand-skill-persistence/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Medical 3D Printing with Jenny Chen of 3DHeals</title>
		<link>https://3dheals.com/medical-3d-printing-with-jenny-chen-of-3dheals/</link>
					<comments>https://3dheals.com/medical-3d-printing-with-jenny-chen-of-3dheals/#respond</comments>
		
		<dc:creator><![CDATA[3DHEALS]]></dc:creator>
		<pubDate>Sun, 21 May 2017 08:54:56 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[3dheals Community Activities]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Ideas]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[interview]]></category>
		<category><![CDATA[medical 3dprinting]]></category>
		<category><![CDATA[surgical planning]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2577</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>By Tracy Leigh Hazzard and Tom Hazzard This article/interview was originally published on 3dstartpoint.com. &#160; 3DHEALS2017: UCSF 3D Printing Library The single most important challenge that people need to realize is that there is a lack of conversation between different disciplines. We have a few challenges about the images that we have. One is, these [&#8230;]</p>
<p>The post <a href="https://3dheals.com/medical-3d-printing-with-jenny-chen-of-3dheals/">Medical 3D Printing with Jenny Chen of 3DHeals</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p class="graf graf--p">By <strong class="markup--strong markup--p-strong">Tracy Leigh Hazzard and Tom Hazzard</strong></p>
<p class="graf graf--p"><a class="markup--anchor markup--p-anchor" href="https://3dstartpoint.com/medical-3d-printing-with-jenny-chen-of-3dheals/" target="_blank" rel="noopener noreferrer" data-href="https://3dstartpoint.com/medical-3d-printing-with-jenny-chen-of-3dheals/">This article/interview was originally published on 3dstartpoint.com.</a></p>
<p>&nbsp;<img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/05/1-_nIhOYrEMJQKs-X48bzyg.jpeg"></p>
<p>3DHEALS2017: UCSF 3D Printing Library</p>
<p style="text-align: left;">
The single most important challenge that people need to realize is that there is a lack of conversation between different disciplines.</p>
<p class="graf graf--p">We have a few challenges about the images that we have. One is, these images are not obtained based on any standard.</p>
<p class="graf graf--p">3D printing could be doing so much more for healing real people if there is a greater connection, if they close that communication gap between 3D printing and the medical community.</p>
<p class="graf graf--p">3DHEALS2017: RECAP</p>
<p style="text-align: left;">&nbsp;</p>
<p>The post <a href="https://3dheals.com/medical-3d-printing-with-jenny-chen-of-3dheals/">Medical 3D Printing with Jenny Chen of 3DHeals</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/medical-3d-printing-with-jenny-chen-of-3dheals/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>3D Printing’s Legal Landscape Remains Wild, Untamed</title>
		<link>https://3dheals.com/3d-printings-legal-landscape-remains-wild-untamed/</link>
					<comments>https://3dheals.com/3d-printings-legal-landscape-remains-wild-untamed/#respond</comments>
		
		<dc:creator><![CDATA[Eric Barnes]]></dc:creator>
		<pubDate>Sun, 21 May 2017 08:31:33 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[3dheals Community Activities]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[legal]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2563</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>By Eric Barnes, AuntMinnie.com staff writer This article was originally published on AuntMinnie.com on April 25, 2017. &#8220; 3DHEALS2017: Regulatory Panel, April 20th, 2017 &#160; April 25, 2017 &#8212; Many of the qualities that make 3D printing such an exciting field are the same ones that create a perilous legal environment for the industry, according [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3d-printings-legal-landscape-remains-wild-untamed/">3D Printing’s Legal Landscape Remains Wild, Untamed</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p class="graf graf--p">By <a class="markup--anchor markup--p-anchor" href="https://www.linkedin.com/in/eric-barnes-4312a35/" target="_blank" rel="noopener noreferrer" data-href="https://www.linkedin.com/in/eric-barnes-4312a35/">Eric Barnes</a>, AuntMinnie.com staff writer</p>
<p class="graf graf--p" style="text-align: left;"><a href="http://www.auntminnie.com/index.aspx?sec=sup&amp;sub=adv&amp;pag=dis&amp;ItemID=117176">This article was originally published on AuntMinnie.com on April 25, 2017.</a></p>
<p class="graf graf--p graf-after--p" style="text-align: left;"><img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/05/1-JGp4-ch7AGIGqZU5HqGyYQ.jpeg">&#8220;</p>
<p class="graf graf--p" style="text-align: center;">3DHEALS2017: Regulatory Panel, April 20th, 2017</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span class="maStartDate">April 25, 2017</span> &#8212; Many of the qualities that make 3D printing such an exciting field are the same ones that create a perilous legal environment for the industry, according to experts at last week&#8217;s 3DHeals conference. From patent protections to product liability, 3D printing&#8217;s sparse legal track record and unique manufacturing processes raise issues that lack clear answers.</p>
<p>At a panel session discussing these issues at the San Francisco conference, intellectual property specialist Eric Birkeneder, from the Nixon Peabody law firm, and Colleen Davies, a partner at Reed Smith and a member of the firm&#8217;s Life Sciences Health Industry Group, talked about law in the emerging field.<br />
Birkeneder said his firm started working in intellectual property in issues related to 3D printing about a year and a half ago, about when Nixon Peabody pulled together a task force to gather knowledge and create strategies for the field.<br />
<strong>Protecting intellectual property</strong><br />
&#8220;Traditionally, we want to protect the product with patenting and maybe sometimes the process for making it. But for 3D printing, there are so many different products and processes that can be patented, including scans if you&#8217;re doing medical implants,&#8221; Birkeneder said.</p>
<h1><a href="http://www.auntminnie.com/index.aspx?sec=sup&amp;sub=adv&amp;pag=dis&amp;ItemID=117176">Read more&#8230;</a></h1>
<p>The post <a href="https://3dheals.com/3d-printings-legal-landscape-remains-wild-untamed/">3D Printing’s Legal Landscape Remains Wild, Untamed</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3d-printings-legal-landscape-remains-wild-untamed/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Mr. Tamer Mohamed</title>
		<link>https://3dheals.com/3dheals-influencer-interview-series-mr-tamer-mohamed/</link>
					<comments>https://3dheals.com/3dheals-influencer-interview-series-mr-tamer-mohamed/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Wed, 29 Mar 2017 17:24:42 +0000</pubDate>
				<category><![CDATA[Bio-printing / Regenerative Medicine]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[Innovator's Story]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[tissue engineering]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2467</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Q: What is your vision for bioprinting? A: The applications of bioprinting technology will continue to rapidly advance and will have a major impact on drug development, personalized medicine, and organ transplantation. I imagine a future where life-saving drugs are more efficiently developed without the use of animals, where doctors can determine how a patient [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-mr-tamer-mohamed/">Interview: Mr. Tamer Mohamed</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your vision for bioprinting?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A:</strong> The applications of bioprinting technology will continue to rapidly advance and will have a major impact on drug development, personalized medicine, and organ transplantation. I imagine a future where life-saving drugs are more efficiently developed without the use of animals, where doctors can determine how a patient will react to a drug before prescribing it, and where replacement organs can be 3D printed using a patient’s own cells, without dealing with wait lists or organ rejection. This is a future that could be enabled by bioprinting technology.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you specialize in?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A: </strong>Our team at Aspect Biosystems is focused on developing tissues for pre-clinical drug development. An example of this includes a 3D bioprinted tissue that models airway constriction and relaxation. This bioprinted tissue is being used in the development of novel asthma therapeutics. We also focus on developing 3D tissues for clinical applications. A key part of our strategy involves partnering with best-in-class pharma and biotech firms to develop impactful application of our platform technology. An example of this is a collaboration between Aspect and Johnson and Johnson where we are working closely to develop 3D printed knee meniscus tissue for surgical therapy.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">Q: What inspires you to do what you do?</strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A:</strong> I am inspired by the amazing potential of bioprinting technology in changing the way we develop drugs and treat disease. I am also inspired by our team at Aspect. Our team of world-class scientists and engineers is constantly pushing the boundaries of our technology with the goal of ultimately making a meaningful impact on patients.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the best business lesson you have learned?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A:</strong> Starting a business is hard. As Elon Musk says, “starting a company is like eating glass and staring into the abyss”. Having a deep passion and excellent team to get through the difficulties of starting a business is crucial.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: How do you ensure you’re making informed decisions?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A:</strong> Surrounding myself with smart people I trust, taking their feedback critically, and gathering relevant and current information and data.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: How will bioprinting impact pharma R&amp;D?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A:</strong> The pre-clinical phase of drug development is in need of increased physiological relevance. Bioprinting will enable us to create tissues that are more predictive of the human response to drugs. Using bioprinted tissues in pre-clinical drug development will allow us to eliminate drugs that won’t work or are unsafe in humans sooner, and take safe and effective drugs into clinical trials with a higher chance of success.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: How will bioprinting impact regenerative medicine?</em></strong></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong">A: </strong>Medicine is going to get a lot more personalized, and this is where bioprinting really shines — it’s a customization platform. I imagine in the not so distant future, we will be creating tissues that are customized to your own body, made up of your own cells, to replace diseased tissue.</p>
<p class="graf graf--p"><img fetchpriority="high" decoding="async" class="alignnone" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg" alt="" width="1920" height="1427"></p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-mr-tamer-mohamed/">Interview: Mr. Tamer Mohamed</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-influencer-interview-series-mr-tamer-mohamed/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Prof. Ali Khademhosseini</title>
		<link>https://3dheals.com/interview-prof-ali-khademhosseini/</link>
					<comments>https://3dheals.com/interview-prof-ali-khademhosseini/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Mon, 27 Mar 2017 13:57:57 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[Bio-printing / Regenerative Medicine]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[Innovator's Story]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[influencer]]></category>
		<category><![CDATA[innovator]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2455</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Brigham and Women’s Hospital, Harvard Medical School — Harvard and Harvard-MIT Division of Health Sciences and Technology. Ali Khademhosseini is Professor of Medicine at Harvard Medical School and Director of the Biomaterials Innovation Research Center at Brigham and Women’s Hospital. He is also a faculty at the Harvard-MIT Division of Health Sciences and Technology as well as [&#8230;]</p>
<p>The post <a href="https://3dheals.com/interview-prof-ali-khademhosseini/">Interview: Prof. Ali Khademhosseini</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p><img decoding="async" class="alignnone size-medium wp-image-2456" src="https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-300x300.jpg" alt="Ali Khademhosseini Interview Series" width="300" height="300" srcset="https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-300x300.jpg 300w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-245x245.jpg 245w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-100x100.jpg 100w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-447x447.jpg 447w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-150x150.jpg 150w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-400x400.jpg 400w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1-510x510.jpg 510w, https://3dheals.com/wp-content/uploads/2017/03/Ali-K1.jpg 512w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p class="graf graf--p" style="text-align: justify;">Brigham and Women’s Hospital, Harvard Medical School — Harvard and Harvard-MIT Division of Health Sciences and Technology.</p>
<p class="graf graf--p" style="text-align: justify;"><span class="graf-dropCap">A</span><a class="markup--anchor markup--p-anchor" href="https://www.linkedin.com/in/alikmit/" target="_blank" rel="noopener" data-href="https://www.linkedin.com/in/alikmit/">li Khademhosseini</a> is Professor of Medicine at Harvard Medical School and Director of the Biomaterials Innovation Research Center at Brigham and Women’s Hospital. He is also a faculty at the Harvard-MIT Division of Health Sciences and Technology as well as an Associate Faculty at the Wyss Institute for Biologically Inspired Engineering and a Junior PI at Japan’s World Premier International-Advanced Institute for Materials Research at Tohoku University where he directs a satellite laboratory. He is recognized as a leader in combining micro- and nano-engineering approaches with advanced biomaterials for regenerative medicine applications. In particular, his laboratory has pioneered numerous technologies and materials for controlling the architecture and function of engineered vascularized tissues. He has authored over 500 journal papers (H-index = 86, ~29,000 citations) and 50 books/chapters. In addition, he has delivered 300+ invited/keynote lectures.Dr. Khademhosseini’s interdisciplinary research has been recognized by over 40 major national and international awards. He is a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government for early career investigators. He is also a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Fellow of the Biomaterials Sciences and Engineering (FBSE) and American Association for the Advancement of Science (AAAS). Currently he serves on the editorial board of numerous leading journals as well as an Associate Editor for ACS Nano (IF: 12) and a permanent member of NIH BTSS study section. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering. Read more at: <a class="markup--anchor markup--p-anchor" href="http://www.tissueeng.net/" target="_blank" rel="noopener" data-href="http://www.tissueeng.net/">http://www.tissueeng.net/</a>.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your vision on the intersection of 3D Printing and healthcare?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I envision that 3D printing can create a wide variety of products with a huge impact on healthcare. Such products, in the form of tissues and organs for tissue regeneration and drug testing will bring a paradigm shift in the fields of personalized prosthetics, implants, and anatomical models.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you specialize in? What is your passion?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A: </strong>My research is focused on developing micro- and nano scale biomaterials to control cellular behavior with particular emphasis on developing engineered materials and systems for tissue engineering. In particular, I am passionate about developing various approaches to merge micro fabrication techniques such as 3D bioprinting, photo lithography, and microfluidics with hydrogel biomaterials for directing cell organization and generating complex 3D tissues. I am also developing ‘organ-on-a-chip’ systems that aim to mimic human response to various chemicals <em class="markup--em markup--p-em">in vitro</em>. In addition, my laboratory is developing technologies to control the formation of vascularized tissues with appropriate micro architectures as well as regulating stem cell differentiation within micro engineered systems.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What inspired you to do what you do?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> A passion for science and bringing technologies that make a change for the larger good is what inspired me. I have been lucky to have had my education under the shadows of some great scientists who have brought ground breaking concepts and technologies from bench to bedside that continue to change the lives of millions.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest potential impact you see 3D printing having on the healthcare industry?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> The application of 3D bioprinting technologies in healthcare industry can provide many potential impacts, including: the customization and personalization of medical products, drugs, and equipment, cost-effectiveness, increased productivity, the democratization of design and manufacturing, and enhanced collaboration.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What challenges do you see arising in implementing 3D printing in healthcare sector in the next 5 years?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> A major challenge in making large tissues is vascularization. The pace at which the 3D bioprinting technology is developing, I see it is not a distant dream to achieve.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the best business lesson you have learned?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I have learned that to enable biofabricated products, a synergy of multidisciplinary scientific fields such as mechanics, computer science, biomaterials, biology, tissue engineering, etc. is required for a successful translation. There is always a market for technologies that are disruptive in their approach to address a particular health problem.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest business risk you have taken?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> It was to accept a job offer at Harvard Medical School as it is a very challenging environment.</p>
<p class="graf graf--p">[et_pb_image src=&#8221;<img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg">&#8221; show_in_lightbox=&#8221;off&#8221; url_new_window=&#8221;off&#8221; use_overlay=&#8221;off&#8221; animation=&#8221;left&#8221; sticky=&#8221;off&#8221; align=&#8221;left&#8221; force_fullwidth=&#8221;off&#8221; always_center_on_mobile=&#8221;on&#8221;][/et_pb_image]</p>
<p>The post <a href="https://3dheals.com/interview-prof-ali-khademhosseini/">Interview: Prof. Ali Khademhosseini</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/interview-prof-ali-khademhosseini/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview Series: Yan Chow</title>
		<link>https://3dheals.com/3dheals-influencer-interview-series-yan-chow/</link>
					<comments>https://3dheals.com/3dheals-influencer-interview-series-yan-chow/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Thu, 23 Mar 2017 18:19:19 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[economics]]></category>
		<category><![CDATA[entreprenuer]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovator]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2447</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Yan Chow, MD, MBA is a Medical Director in the Medical Sciences Early Development Group at Amgen, a leading human therapeutics biotechnology company. His prior engagements include Chief Innovation Officer at LongView International Technology Solutions, a federal health IT services provider ranked #5 in Washington Technology Magazine’s 2014 Fast50 list; and former national Medical Director [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-yan-chow/">Interview Series: Yan Chow</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p><img decoding="async" class="alignnone size-full wp-image-2448" src="https://3dheals.com/wp-content/uploads/2017/03/Yan-Chow.jpg" alt="Yan Chow interview series" width="200" height="200" srcset="https://3dheals.com/wp-content/uploads/2017/03/Yan-Chow.jpg 200w, https://3dheals.com/wp-content/uploads/2017/03/Yan-Chow-100x100.jpg 100w, https://3dheals.com/wp-content/uploads/2017/03/Yan-Chow-150x150.jpg 150w" sizes="(max-width: 200px) 100vw, 200px" /></p>
<p class="graf graf--p graf--hasDropCapModel graf--hasDropCap" style="text-align: justify;"><span class="graf-dropCap">Y</span><a class="markup--anchor markup--p-anchor" href="https://www.linkedin.com/in/yanchow/" target="_blank" rel="noopener" data-href="https://www.linkedin.com/in/yanchow/"><em class="markup--em markup--p-em">an Chow</em></a><em class="markup--em markup--p-em">, MD, MBA is a Medical Director in the Medical Sciences Early Development Group at Amgen, a leading human therapeutics biotechnology company.</em></p>
<p class="graf graf--p"><em class="markup--em markup--p-em">His prior engagements include Chief Innovation Officer at LongView International Technology Solutions, a federal health IT services provider ranked #5 in Washington Technology Magazine’s 2014 Fast50 list; and former national Medical Director of the Innovation &amp; Advanced Technology Group (IAT) at Kaiser Permanente, the largest private integrated care delivery system in the nation.</em></p>
<p class="graf graf--p"><em class="markup--em markup--p-em" style="text-align: justify;">IAT assessed and made internal recommendations on over 2,000 new and emerging clinical information technologies with the potential to impact health care within a decade. Primary areas of focus were telehealth, mobile, and analytics, but many other areas were included, such as interfaces, IoT, robotics, social media, genomics, and behavioral research.In addition, IAT operated a successful employee innovation grant program.</em></p>
<p class="graf graf--p" style="text-align: justify;"><em class="markup--em markup--p-em">IAT is affiliated with KP’s Garfield Innovation Center, an award-winning care delivery simulation laboratory that hosted over 55,000 visitors, including delegations from 43 countries, in its first eight years of operation.</em></p>
<p class="graf graf--p"><em class="markup--em markup--p-em" style="text-align: justify;">Dr. Chow hasadvised and founded a number of startups, including a venture-funded analytics startup. He has 3 U.S. patents.</em></p>
<p class="graf graf--p"><em class="markup--em markup--p-em" style="text-align: justify;">Dr. Chow earned his A.B. with honors from Harvard University and his M.D. from UC San Diego. In 2005 he received his MBA from UC Berkeley, where he graduated as valedictorian.</em></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your vision on the intersection of 3D Printing and healthcare?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I believe the new field of 3D bioprinting makes possible a potentially massive expansion of the therapeutic repertoire that healthcare providers can draw upon to fight disease and improve the human condition. The ability to create customized tools and medical products on a just-in-time basis promises to make health care much more efficient, personalized, and accessible. It also portends the increasing role of the patient in shaping his or her own health care, which is a good thing.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you specialize in? What is your passion?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> My interests are in the area of healthcare technology innovation, particularly technology strategy. The pace of innovation is increasing exponentially, driven by progress in multiple technology domains as well as new and unique synergies between domains. These are as diverse as wireless tech, big data, telemedicine, IoT, robotics, interfaces, 3D printing, nanotech, cyber security, human behavior, genomics, and medical research. The result is a tremendous amount of noise and uncertainty. The challenge is to focus on use cases compelling enough to drive adoption in highly risk-averse industries like the healthcare and pharmaceutical industries.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What inspired you to do what you do?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> As a youngster, I loved to read science fiction. I grew up in an era when the common person was beginning to be enthralled by the potential for technological achievement, such as landing on the moon or exploring the depths of the ocean. Authors like Isaac Asimov and Robert Heinlein painted fantastic pictures of life in the distant future, mostly oriented around technology. Today, many of those depictions have become reality, and it’s actually challenging to find a feasible tech scenario that is far enough in the future to be labeled ‘sci-fi’ — with the exception, perhaps, of time travel.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest potential impact you see 3D printing having on the healthcare industry?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> This probably depends on the time frame. In the long term, I think the greatest impact will come from 3D bioprinting of tissues and organs for repair, replacement, and research. However, some areas, such as enhancement of human ability beyond what is naturally possible, will call forserious ethical, moral, legal, and regulatory discussion.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What challenges do you see arising in implementing 3D printing in healthcare sector in the next 5 years?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A: </strong>One of the major challenges will be how to regulate 3D bioprinted products and tools for safety and efficacy, especially since these products are often customized, and the venues and means of production distributed, heterogeneous, and not controlled for quality and reliability. Regulatory scrutiny should be appropriate to the level of medical risk posed by a 3D-printed item (an implant, for instance, would be high risk). One possibility is that some elements of the traditional manufacturing process may need to go with a 3D medical printer, such as printing precision, a quality auditing system, or even a mini clean room or cleaning system.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the best business lesson you have learned?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> There are quite a few lessons I’ve learned (and forgotten). One of the most important is to try to see through someone else’s eyes. Try to understand what your customer is thinking, not just in the scenario you’re dealing with, but broadly as part of an ecosystem that you may or may not be familiar with. Why are they reluctant to adopt your product or service even when the logic seems impeccable? It might bea good exercise to alsodo this with your end users, investors, competitors, partners, regulators, and payers.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest business risk you have taken?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> Co-founding a startup has to be near the top of the list. It takes a certain kind of personality and mindset to want to spend time, effort, and money to pursue a dream. The strange thing is that most entrepreneurs don’t see their startup ventures as risky. The trade-offs and sacrifices they make seem reasonable for what they are hoping to achieve, whether commercial success or a social good (or both). As an entrepreneur, you must hold a powerful belief in your idea, and sometimes this belief can make it difficult to understand why the world does not immediately beat a path to your doorstep.</p>
<p class="graf graf--p" style="text-align: justify;">&nbsp;src=&#8221;<img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg"></p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-yan-chow/">Interview Series: Yan Chow</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-influencer-interview-series-yan-chow/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Amy Karle</title>
		<link>https://3dheals.com/3dheals-influencer-interview-series-amy-karle/</link>
					<comments>https://3dheals.com/3dheals-influencer-interview-series-amy-karle/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Wed, 22 Mar 2017 15:08:29 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[art]]></category>
		<category><![CDATA[autodesk]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[science]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2438</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Amy Karle is an artist who explores what it means to be human through a unique mergence of art, design, science and technology. She creates sculptures, wearables, garments, experiences and performances to create representations of our internal states and processes so that we may study the mind and body and even learn to reprogram it. [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-amy-karle/">Interview: Amy Karle</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p class="graf graf--p graf--hasDropCapModel graf--hasDropCap" style="text-align: justify;"><img loading="lazy" decoding="async" class="alignnone size-medium wp-image-2442" src="https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle-300x300.jpeg" alt="Amy Karle interview series" width="300" height="300" srcset="https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle-300x300.jpeg 300w, https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle-245x245.jpeg 245w, https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle-100x100.jpeg 100w, https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle-150x150.jpeg 150w, https://3dheals.com/wp-content/uploads/2017/03/Amy-Karle.jpeg 400w" sizes="auto, (max-width: 300px) 100vw, 300px" /></p>
<p class="graf graf--p graf--hasDropCapModel graf--hasDropCap" style="text-align: justify;"><span class="graf-dropCap">A</span><a class="markup--anchor markup--p-anchor" href="https://www.linkedin.com/in/amykarle/" target="_blank" rel="noopener" data-href="https://www.linkedin.com/in/amykarle/"><em class="markup--em markup--p-em">my Karle</em></a><em class="markup--em markup--p-em"> is an artist who explores what it means to be human through a unique mergence of art, design, science and technology. She creates sculptures, wearables, garments, experiences and performances to create representations of our internal states and processes so that we may study the mind and body and even learn to reprogram it. Her bioart work has established a new discipline in the art world.&nbsp;</em></p>
<p class="graf graf--p" style="text-align: justify;"><em class="markup--em markup--p-em">As an artist and designer, Karle is also a provocateur and a futurist, leveraging new technologies to create art and design that catalytically examines material and spiritual aspects of life and open minds to future visions of how technology could be utilized to support and enhance humanity.</em></p>
<p class="graf graf--p" style="text-align: justify;"><em class="markup--em markup--p-em">Amy Karleis co-founder of Conceptual Art Technologies and has shown work in 46 exhibitions worldwide. She is the developer and owner of registered active patents, servicemarks and trademarks in medical and technology categories for enhancing the body and self.</em></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your vision on the intersection of 3D Printing and healthcare?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I believe 3D printing for healthcare is the most disruptive use of 3D printing — the area that I believethis technologycan make the largest positive impact on humanity.My vision for additive manufacture in healthcareis a future factory where a few patient’s cells could be expanded into blood, bones, tissue, organs, even implantable technologies and augmentations out of their own genetic material to heal, extend and enhance their body.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you specialize in? What is your passion?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;">I specialize in creating fine art and design about and for the human body, it is my passion and has been since I was a young child. Although I often rely on my classical training in Art and Design and Philosophy, over the past 18 years my expertise has developed in the conceptual development and execution of creating art and design through new media and digital technologies. Fond of challenging myself, I find working with new technologies and digital manufacturing encourages new ways of thinking. I love the idea that using different technologies can reshape our thinking, and even reshape our brains and our bodies. It keeps me coming back for more… to keep growing as a professional and as a person. I also like to challenge the tools that I work with, so we can develop together to create things that couldn’t be made in another other way. It’s a passion and drive to contribute to our progression.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What inspired you to do what you do?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A: </strong>I have always been fascinated by the human body and the mysteries of life, a compelling and constant curiosity about why we are here, how our bodies work, the mystery of life and the human condition — why we experience pain and suffering as well as love and elation. I was born with a life threatening birth defect and from that experience grew up with the interest in healing and augmenting the body, starting with my own. My parents were both pharmacists and biochemists, and I grew up in the lab and pharmacy with them. They had a lot to do with inspiring me and supporting me on my path as well.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest potential impact you see 3D printing having on the healthcare industry?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> The biggest potential impact that I see 3D printing, including bioprinting can have on the healthcare industry is to heal and augment our bodies,for life extension and creating new life forms and systems to enhance our society, lives and well being.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What challenges do you see arising in implementing 3D printing in healthcare sector in the next 5 years?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> As we move into the 4th industrial revolution, customization and automatization are affecting almost every industry, healthcare included. It’s easy to foresee many challenges in integrating new paradigms and tools into previously established systems. Time, cost and process, including thought processes are big ones, as well aschallenges arising in ethics and lawmaking, speed of being able to use the technologies and apply them to patients/industry, approval and standard systems (ie FDA approval), cost and integration for ease of usability.The biggest challenge I see is one of a paradigm shift: implementing a new way of thinking about what is possible to create with new tools and technologies, including how to innovate in one’s own work.I believe questions and answers and overcoming these challenges are in how we encourage new ways of thinking and innovating with digital manufacturing to help solve our healthcare problems. When we can envision how these technologies can benefit and serve more people, even increase the bottom line, there becomes more energy and resources to face challenges.</p>
<p class="graf graf--p" style="text-align: justify;">I believe that once the technologies and their potentials are understood and embraced by healthcare sector, the path will be paved for restructuring established systems to accommodate and fund.Poignant discussions and problem solving in how to overcome those challenges can offer innovations in itself. To overcome challenges, I strongly believe in the importance of cross-disciplinary collaboration to benefit all fields involved. For example, I created my piece “Regenerative Reliquary”, 2016 as a piece of artwork and speculative design, however, collaborating with scientists to achieve the requirements of the art piece bypassed obstacles that would have been present if this was created as scientific research, advanced the technology, made scientific achievements and told stories about otherwise complex science and medical futuring to a larger audience.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the best business lesson you have learned?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> To be a professional and businessperson in totality of what you do, whatever field you are in. Regardless of if you work for yourself or someone else, back up your passion with strategy. Continually push and challenge yourself to identify and fulfill needs.When a project seems improbable, it doesn’t mean that it is. It’s up to you to believe in it, believe in yourself and keep going.It’s important to know your “why” and share that with others, even if you don’t know “how; when you are passionate it is magnetic and attracts the support to resolve the “how”. Have the inner confidence to ask for the expertise and support of others. Do not fear success or failure, do your best to be emotionally detached to the outcome in this way — keep going and keep working.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest business risk you have taken?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> Starting my own business working as a full time professional artist and designer.Some projects are total risks: I put in so much energy, time and resources and I don’t know if they will work or what will come of them. When I feel concerned I reassure myself that if nothing else, I will learn and grow in the process, so something will come out of the effort and investment even if I don’t deem the outcome otherwise successful.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you think the biggest difference between an artist and a scientist is?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> As I see it, artists, designers and scientists all have this shared desire to make sense of nature and our world, we just study, execute and share it in different ways. Scientists tend to perform research towards understanding; artists create work on their perception or to support understanding; and designers create products to support others’ understanding and utilization of understanding; which quickly comes full circle to applied science. The biggest differences are in the execution and methods, need for replicable results and aesthetics. Its really how one practices that defines art and science as the same or different.In my opinion, there is an opportunity to develop both the art and the scienceof every profession, and that is the key to differentiating oneself and achieving success no matter what field you are in.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: How does it feel to be a scientific artist?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> Very natural and very dynamic at the same time. It is instinctive for me to contemplate the body, nature, philosophy and science and express those questions and reflections in my work.I identify as an artist; artwork is how I express myself best and the language I speak most fluently but I’ve have always had a flirtation with science, so to be interested in science and want to explore and express that in my work feels very natural. It also feels very dynamic because I often find myself so focused on learning from the science and technology, while trying to push it and utilize it in a way to create cutting edge artwork that there becomes a dynamic tension between creating the work and the work itself.Those boundaries dissolve when you get so good at the tools or the medium that you can express yourself and your work through it without thinking about it — completely from an intuitive place. That’s when it will all feel natural. I’m not there yet. In the meantime, it’s a challenging momentum pushing me forward.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your hope for the scientific community to contribute to the 3DP community/technology in general? And vice versa?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I hope the scientific community contributes new ways of using 3D technology and new ways of thinking about how to use it. I hope they provide visions and innovations of new tools, processes and technologies based on their needs, hopes and goals. My hope is that the technology community collaborates with scientists and other fields alike to develop and create new tools.</p>
<p class="graf graf--p"><img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg"></p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-series-amy-karle/">Interview: Amy Karle</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-influencer-interview-series-amy-karle/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Dr. Richard Underwood</title>
		<link>https://3dheals.com/interview-dr-richard-underwood/</link>
					<comments>https://3dheals.com/interview-dr-richard-underwood/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Wed, 22 Mar 2017 15:05:07 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dheals2017]]></category>
		<category><![CDATA[Exponent]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[regulation]]></category>
		<category><![CDATA[safety]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2440</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Dr. Underwood is a Manager in the Biomedical Engineering Practice at Exponent’s Philadelphia Office. He is a Chartered Engineer and Member of the Institution of Mechanical Engineers.He specializes in the tribological performance of mechanical systems and is an experienced metrologist.&#160; Dr. Underwood is a Visiting Research Professor at the Implant Retrieval Center, Department of Biomedical [&#8230;]</p>
<p>The post <a href="https://3dheals.com/interview-dr-richard-underwood/">Interview: Dr. Richard Underwood</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p><img loading="lazy" decoding="async" class="alignnone size-medium wp-image-2441" src="https://3dheals.com/wp-content/uploads/2017/03/underwood_web-242x300.jpg" alt="Richard Underwood interview series" width="242" height="300" srcset="https://3dheals.com/wp-content/uploads/2017/03/underwood_web-242x300.jpg 242w, https://3dheals.com/wp-content/uploads/2017/03/underwood_web.jpg 329w" sizes="auto, (max-width: 242px) 100vw, 242px" /></p>
<p class="graf graf--p graf--hasDropCapModel graf--hasDropCap" style="text-align: justify;"><span class="graf-dropCap">D</span><em class="markup--em markup--p-em">r. </em><a class="markup--anchor markup--p-anchor" href="https://www.linkedin.com/in/richard-underwood-319a93b8/" target="_blank" rel="noopener" data-href="https://www.linkedin.com/in/richard-underwood-319a93b8/"><em class="markup--em markup--p-em">Underwood</em></a><em class="markup--em markup--p-em"> is a Manager in the Biomedical Engineering Practice at Exponent’s Philadelphia Office. He is a Chartered Engineer and Member of the Institution of Mechanical Engineers.He specializes in the tribological performance of mechanical systems and is an experienced metrologist.&nbsp;</em></p>
<p class="graf graf--p"><em class="markup--em markup--p-em">Dr. Underwood is a Visiting Research Professor at the</em> <em class="markup--em markup--p-em">Implant Retrieval Center, Department of Biomedical Engineering and Health Systems at Drexel University. His research interests include the tribological performance of orthopedic devices and the effect of design, manufacturing, lubrication mechanisms, wear mechanisms, and surgical/patient factors on the in-vivo performance of orthopedic devices.Dr. Underwood is an active member of the ASTM, gives regular guest lectures, is a reviewer for several orthopedic and tribology journals, and has chaired sessions at international conferences. One of Dr. Underwood’s current interests is the application of additive manufacturing to medical devices.</em></p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is your vision on the intersection of 3D Printing and healthcare?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> 3D Printing has the potential to disrupt the medical device landscape as we know it by allowing the mass customization of medical devices, taking manufacturing away from traditional factories and into the clinical environment.</p>
<p class="graf graf--p">In the future, traditional medical device companies will design customizable implants, where the key dimensions and parameters of the device can be modified locally by physicians within an overall design envelope. The medical device company will have developed and tested the device within the design envelope and will provide the necessary software and hardware to allow physicians to go directly from patient imaging to the final manufactured device.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What inspired you to do what you do?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> I have always wanted to know how things have worked since I was a child, and coming from a family of engineers it was natural that this curiosity would lead to me becoming a mechanical engineer. My time at the University, both as a student and researcher, has provided me with a skill set and passion to apply engineering principles to solve real life problems.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What do you specialize in? What is your passion?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> By training I am a mechanical engineer, and I am currently working in the biomedical engineering practice at Exponent, a scientific and engineering consulting company. Often working in multidisciplinary teams, I apply my engineering and scientific training and experience to solving the complex problems of our clients. I get a real buzz from helping our clients to achieve their goals.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest potential impact you see 3D printing having on the healthcare industry?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> The adoption of additive manufacturing technologies in the health care industries depends a lot on the regulatory framework implemented by the FDA. The end goal — mass customization — will depend on companies developing a design and manufacturing processes that allow individual patient data to be used in the design and manufacturing of devices. If the standardization bodies such as the ASTM and ISO are able to develop the necessary standards to allow the safe application of this technology, and the FDA develops the framework to allow local manufacturing, the current manufacturing paradigm maybe turned upside down.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What challenges do you see arising in implementing 3D printing in healthcare sector in the next 5 years?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> Additive manufacture holds the promise of mass customization of medical devices, the possibility of doctors designing bespoke devices based on individual patient anatomy and then creating the device using a 3D printer in their office. However, in order to achieve this potential, it will be necessary to develop a whole new design and manufacturing eco system, within a framework of regulation from the FDA, covering the imaging, design, software, manufacturing, sterilization, and quality systems.</p>
<p class="graf graf--p" style="text-align: justify;">The challenge for engineers and clinicians will be to develop the tools and software to allow doctors to seamlessly customize standardized designs with an overall design envelope, based on patient imaging, perform the necessary design validation and verification, and then print the parts using the 3D printer in their office, which is also validated and verified. Finally, the finished part must be verified to ensure that the dimensions and material properties meet the design specifications. All of these processes must comply with the regulatory requirements and be documented.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the best business lesson you have learned?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> It is cliché, but to succeed you need to invest time and work hard.</p>
<p class="graf graf--p"><strong class="markup--strong markup--p-strong"><em class="markup--em markup--p-em">Q: What is the biggest business risk you have taken?</em></strong></p>
<p class="graf graf--p" style="text-align: justify;"><strong class="markup--strong markup--p-strong">A:</strong> After I finished my postdoctoral research at Imperial College London, I left the UK and moved to the US to start a job with Exponent. America is still the land of endless opportunities!</p>
<p class="graf graf--p" style="text-align: justify;">&nbsp;src=&#8221;<img decoding="async" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg"></p>
<p class="graf graf--p">&nbsp;</p>
<p>The post <a href="https://3dheals.com/interview-dr-richard-underwood/">Interview: Dr. Richard Underwood</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/interview-dr-richard-underwood/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
